EUVIMEDEUVIMED entdecken
Open Access

SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months–4 Years — New Vaccine Surveillance Network, United States, July 2022–September 2023

Ayzsa Tannis, Janet A Englund, Ariana Perez, Elizabeth J Harker, Mary Allen Staat, Elizabeth P Schlaudecker, Natasha B Halasa, Laura S Stewart, John V Williams, Marian G Michaels, Rangaraj Selvarangan, Jennifer E Schuster und 9 weitere

MMWR. Morbidity and Mortality Weekly Report · 2023

DOI: 10.15585/mmwr.mm7248a2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, 2023. Verfasst von Ayzsa Tannis und 20 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCIRD CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 infection in young children is often mild or asymptomatic; however, some children are at risk for severe disease. Data describing the protective effectiveness of COVID-19 mRNA vaccines against COVID-19-associated emergency department (ED) visits and hospitalization in this population are limited. Data from the New Vaccine Surveillance Network, a prospective population-based surveillance system, were used to estimate vaccine effectiveness using a test-negative, case-control design and describe the epidemiology of SARS-CoV-2 in infants and children aged 6 months-4 years during July 1, 2022-September 30, 2023. Among 7,434 children included, 5% received a positive SARS-CoV-2 test result, and 95% received a negative test result; 86% were unvaccinated, 4% had received 1 dose of any vaccine product, and 10% had received ≥2 doses. When compared with receipt of no vaccines among children, receipt of ≥2 COVID-19 mRNA vaccine doses was 40% effective (95% CI = 8%-60%) in preventing ED visits and hospitalization. These findings support existing recommendations for COVID-19 vaccination of young children to reduce COVID-19-associated ED visits and hospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19VaccinesChildInfantUnited StatesHumansChild, PreschoolCOVID-19 VaccinesSARS-CoV-2Prospective StudiesVaccine EfficacyHospitalizationRNA, Messenger

Substanzen

COVID-19 VaccinesVaccinesRNA, Messenger

Förderung

  • NCIRD CDC HHS

Zitieren

APA

Tannis, A., Englund, J. A., Perez, A., Harker, E. J., Staat, M. A., Schlaudecker, E. P., Halasa, N. B., Stewart, L. S., Williams, J. V., Michaels, M. G., Selvarangan, R., Schuster, J. E., Sahni, L. C., Boom, J. A., Weinberg, G. A., Szilagyi, P. G., Clopper, B. R., Zhou, Y., McMorrow, M. L., …, & Moline, H. L. (2023). SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months–4 Years — New Vaccine Surveillance Network, United States, July 2022–September 2023. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7248a2

Vancouver

Tannis A, Englund JA, Perez A, Harker EJ, Staat MA, Schlaudecker EP, et al. SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months–4 Years — New Vaccine Surveillance Network, United States, July 2022–September 2023. MMWR. Morbidity and Mortality Weekly Report. 2023. doi:10.15585/mmwr.mm7248a2

BibTeX
@article{Tannis2023,
  author = {Tannis, Ayzsa and Englund, Janet A and Perez, Ariana and Harker, Elizabeth J and Staat, Mary Allen and Schlaudecker, Elizabeth P and Halasa, Natasha B and Stewart, Laura S and Williams, John V and Michaels, Marian G and Selvarangan, Rangaraj and Schuster, Jennifer E and Sahni, Leila C and Boom, Julie A and Weinberg, Geoffrey A and Szilagyi, Peter G and Clopper, Benjamin R and Zhou, Yingtao and McMorrow, Meredith L and Klein, Eileen J and Moline, Heidi L},
  title = {SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months–4 Years — New Vaccine Surveillance Network, United States, July 2022–September 2023},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2023},
  doi = {10.15585/mmwr.mm7248a2}
}
Kostenlos starten →